Exicure, Inc. (XCUR)
NASDAQ·Healthcare·Biotechnology
$3.49
-1.97%
Mkt Cap $26.07M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | $1.64M | — | — | -$18.60 | -$0.46 | +97.53% | — | — |
| Q4 2025 Nov 7, 2025 | — | — | — | — | -$0.39 | — | — | — |
| Q3 2025 Aug 8, 2025 | — | — | — | — | -$0.41 | — | — | — |
| Q2 2025 Jun 27, 2025 | — | — | — | — | -$0.45 | — | — | — |
| Q1 2025 Mar 18, 2025 | — | — | — | — | -$3.39 | — | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | — | -$0.57 | — | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | — | -$0.35 | — | — | — |
| Q2 2024 Jun 17, 2024 | — | $500.00K | — | — | -$0.50 | — | — | — |
| Q2 2024 Jun 6, 2024 | $3.90M | $516.00K | -86.77% | — | -$0.68 | — | — | — |
| Q2 2024 May 16, 2024 | $3.90M | — | — | — | -$3.05 | — | — | — |
| Q1 2023 Mar 27, 2023 | $3.90M | $21.77M | +458.31% | -$0.95 | $20.50 | +2257.89% | — | — |
| Q4 2022 Nov 14, 2022 | $3.90M | $2.02M | -48.31% | -$4.50 | -$5.20 | -15.56% | — | — |
| Q3 2022 Aug 15, 2022 | $4.10M | $2.47M | -39.73% | -$1.20 | -$8.30 | -591.67% | — | — |
| Q2 2022 May 16, 2022 | $4.30M | $2.56M | -40.35% | -$2.10 | -$10.51 | -400.48% | — | — |
| Q1 2022 Mar 25, 2022 | $3.50M | $2.12M | -39.49% | -$25.53 | -$22.52 | +11.79% | — | — |
| Q4 2021 Nov 19, 2021 | $2.33M | -$3.68M | -257.81% | -$24.02 | -$40.54 | -68.78% | — | — |
| Q3 2021 Aug 12, 2021 | $1.55M | $79.00K | -94.90% | -$22.52 | -$24.02 | -6.66% | — | — |
| Q2 2021 May 12, 2021 | $830.83K | $997.00K | +20.00% | -$19.52 | -$21.02 | -7.68% | — | — |
| Q1 2021 Mar 11, 2021 | — | $140.00K | — | -$15.02 | -$22.52 | -49.93% | — | — |
| Q4 2020 Nov 12, 2020 | $2.17M | $2.44M | +12.50% | -$13.51 | -$15.02 | -11.18% | — | — |